131 related articles for article (PubMed ID: 25431344)
1. Computerized image analysis of the Ki-67 proliferation index in mantle cell lymphoma.
Blaker YN; Brodtkorb M; Maddison J; Hveem TS; Nesheim JA; Mohn HM; Kolstad A; Geisler CH; Liestøl K; Smeland EB; Holte H; Delabie J; Danielsen H
Histopathology; 2015 Jul; 67(1):62-9. PubMed ID: 25431344
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value and computer image analysis of p53 in mantle cell lymphoma.
Zhang YH; Gao LM; Xiang XY; Zhang WY; Liu WP
Ann Hematol; 2022 Oct; 101(10):2271-2279. PubMed ID: 35918462
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Ki-67 Index, Cytology, and Growth Pattern in Mantle-Cell Lymphoma: Results From Randomized Trials of the European Mantle Cell Lymphoma Network.
Hoster E; Rosenwald A; Berger F; Bernd HW; Hartmann S; Loddenkemper C; Barth TF; Brousse N; Pileri S; Rymkiewicz G; Kodet R; Stilgenbauer S; Forstpointner R; Thieblemont C; Hallek M; Coiffier B; Vehling-Kaiser U; Bouabdallah R; Kanz L; Pfreundschuh M; Schmidt C; Ribrag V; Hiddemann W; Unterhalt M; Kluin-Nelemans JC; Hermine O; Dreyling MH; Klapper W
J Clin Oncol; 2016 Apr; 34(12):1386-94. PubMed ID: 26926679
[TBL] [Abstract][Full Text] [Related]
4. The degree of overlap between the follicular dendritic cell meshwork and tumor cells in mantle cell lymphoma is associated with prognosis.
Hou W; Wei P; Xie J; Zheng Y; Zhang Y; Zhou X
Pathol Res Pract; 2018 Apr; 214(4):513-520. PubMed ID: 29525403
[TBL] [Abstract][Full Text] [Related]
5. Improving precise counting of mitotic cells in mantle cell lymphoma using phosphohistone H3 (PHH3) antibody.
Medani H; Elshiekh M; Naresh KN
J Clin Pathol; 2021 Oct; 74(10):646-649. PubMed ID: 32873701
[TBL] [Abstract][Full Text] [Related]
6. Small cell variant of mantle cell lymphoma is an indolent lymphoma characterized by bone marrow involvement, splenomegaly, and a low Ki-67 index.
Kimura Y; Sato K; Imamura Y; Arakawa F; Kiyasu J; Takeuchi M; Miyoshi H; Yoshida M; Niino D; Sugita Y; Morito T; Yoshino T; Nakamura S; Ohshima K
Cancer Sci; 2011 Sep; 102(9):1734-41. PubMed ID: 21609366
[TBL] [Abstract][Full Text] [Related]
7. Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11.
Croci GA; Hoster E; Beà S; Clot G; Enjuanes A; Scott DW; Cabeçadas J; Veloza L; Campo E; Clasen-Linde E; Goswami RS; Helgeland L; Pileri S; Rymkiewicz G; Reinke S; Dreyling M; Klapper W
Virchows Arch; 2020 Aug; 477(2):259-267. PubMed ID: 31975037
[TBL] [Abstract][Full Text] [Related]
8. Mantle cell lymphoma: 2013 Update on diagnosis, risk-stratification, and clinical management.
Vose JM
Am J Hematol; 2013 Dec; 88(12):1082-8. PubMed ID: 24273091
[TBL] [Abstract][Full Text] [Related]
9. Increased expression of Ki-67 in mantle cell lymphoma is associated with de-regulation of several cell cycle regulatory components, as identified by global gene expression analysis.
Ek S; Björck E; Porwit-MacDonald A; Nordenskjöld M; Borrebaeck CA
Haematologica; 2004 Jun; 89(6):686-95. PubMed ID: 15194536
[TBL] [Abstract][Full Text] [Related]
10. Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma.
Schrader C; Janssen D; Klapper W; Siebmann JU; Meusers P; Brittinger G; Kneba M; Tiemann M; Parwaresch R
Br J Cancer; 2005 Oct; 93(8):939-45. PubMed ID: 16189522
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA signature obtained from the comparison of aggressive with indolent non-Hodgkin lymphomas: potential prognostic value in mantle-cell lymphoma.
Goswami RS; Atenafu EG; Xuan Y; Waldron L; Reis PP; Sun T; Datti A; Xu W; Kuruvilla J; Good DJ; Lai R; Church AJ; Lam WS; Baetz T; Lebrun DP; Sehn LH; Farinha P; Jurisica I; Bailey DJ; Gascoyne RD; Crump M; Kamel-Reid S
J Clin Oncol; 2013 Aug; 31(23):2903-11. PubMed ID: 23835716
[TBL] [Abstract][Full Text] [Related]
12. New paradigms in mantle cell lymphoma: is it time to risk-stratify treatment based on the proliferative signature?
Dreyling M; Ferrero S; Vogt N; Klapper W;
Clin Cancer Res; 2014 Oct; 20(20):5194-206. PubMed ID: 25320369
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma.
Räty R; Franssila K; Joensuu H; Teerenhovi L; Elonen E
Eur J Haematol; 2002 Jul; 69(1):11-20. PubMed ID: 12270057
[TBL] [Abstract][Full Text] [Related]
14. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network.
Tiemann M; Schrader C; Klapper W; Dreyling MH; Campo E; Norton A; Berger F; Kluin P; Ott G; Pileri S; Pedrinis E; Feller AC; Merz H; Janssen D; Hansmann ML; Krieken H; Möller P; Stein H; Unterhalt M; Hiddemann W; Parwaresch R;
Br J Haematol; 2005 Oct; 131(1):29-38. PubMed ID: 16173960
[TBL] [Abstract][Full Text] [Related]
15. New automated image analysis method for the assessment of Ki-67 labeling index in meningiomas.
Grala B; Markiewicz T; Kozłowski W; Osowski S; Słodkowska J; Papierz W
Folia Histochem Cytobiol; 2009; 47(4):587-92. PubMed ID: 20430724
[TBL] [Abstract][Full Text] [Related]
16. Ki-67 Labeling Indices in 'Classic' versus 'Blastoid' Mantle Cell Lymphomas--Proposed Cutoff Values for Routine Diagnostic Workup.
Pervez S; Haroon S; Awan D
Asian Pac J Cancer Prev; 2015; 16(15):6591-4. PubMed ID: 26434879
[TBL] [Abstract][Full Text] [Related]
17. Mantle cell lymphoma shows three morphological evolutions of classical, intermediate, and aggressive forms, which occur in parallel with increased labeling index of cyclin D1 and Ki-67.
Kimura Y; Sato K; Arakawa F; Karube K; Nomura Y; Shimizu K; Aoki R; Hashikawa K; Yoshida S; Kiyasu J; Takeuchi M; Nino D; Sugita Y; Morito T; Yoshino T; Nakamura S; Kikuchi M; Ohshima K
Cancer Sci; 2010 Mar; 101(3):806-14. PubMed ID: 20002441
[TBL] [Abstract][Full Text] [Related]
18. Immunophenotypic variations in mantle cell lymphoma.
Gao J; Peterson L; Nelson B; Goolsby C; Chen YH
Am J Clin Pathol; 2009 Nov; 132(5):699-706. PubMed ID: 19846810
[TBL] [Abstract][Full Text] [Related]
19. Prognostic impact of proliferative index determined by quantitative image analysis and the International Prognostic Index in patients with mantle cell lymphoma.
Schaffel R; Hedvat CV; Teruya-Feldstein J; Persky D; Maragulia J; Lin D; Portlock CS; Moskowitz CH; Zelenetz AD
Ann Oncol; 2010 Jan; 21(1):133-9. PubMed ID: 20019090
[TBL] [Abstract][Full Text] [Related]
20. Variability in morphology and cell proliferation in sequential biopsies of mantle cell lymphoma at diagnosis and relapse: clinical correlation and insights into disease progression.
Vogt N; Klapper W
Histopathology; 2013 Jan; 62(2):334-42. PubMed ID: 23240716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
